A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Midazolam D5 | CAS 395067-42-2 - Request Quote

Picture of Midazolam D5

Midazolam D5

SZ CAT No:SZ-M076D03
CAS No
395067-42-2
Mol.F.
C18H8D5ClFN3
Mol.Wt.
330.8
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Midazolam D5 is chemically 8-Chloro-6-(2-fluorophenyl-3,5-d2)-1-methyl-4H-benzo[f]imidazo[1,5-a][1,4]diazepine-3,4,4-d3. Midazolam D5 is supplied with detailed characterization data compliant with regulatory guideline. Midazolam D5 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Midazolam.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 395067-42-2

Purchase 395067-42-2

Order 395067-42-2

Enquire 395067-42-2

price of 395067-42-2

395067-42-2 Supplier

395067-42-2 Manufacturer

395067-42-2 Exporter

buy high quality Midazolam D5

Purchase Midazolam D5

Midazolam D5 suppliers

Midazolam D5 manufacturers

Midazolam D5 price

Order Midazolam D5

Enquire Midazolam D5

Midazolam D5 cost

Midazolam D5 Supplier

Midazolam D5 Distributor

Midazolam D5 for Method Validation

Midazolam Reference Standard

Midazolam D5 for ANDA Filing

Midazolam D5 for Forced Degradation Studies

Midazolam D5 Identification Standards

Midazolam D5 for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,